Pay in 4 interest-free payments of $6.89 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Systemic benefits minimal or absent
Using the common terminology criteria for adverse events (CTCAE - Version 5.0) to evaluate the severity of adverse events of anticancer therapies
Some patients may notice symptoms returning before their next scheduled injection, particularly if they have higher metabolic demands or ongoing neurological involvement
The IGF-IGFR-IGFBP axis The insulin-like growth factor (IGF) axis encompasses the growth factors IGF-1 and IGF-2, the type 1 and 2 IGF receptors (IGF1R and IGF2R), and a group of six binding proteins (IGFBP-1 to -6) with high affinity for IGF-1 and IGF-2
SCoPE-MS: mass spectrometry of single mammalian cells quantifies proteome heterogeneity during cell differentiation
US$ 22.22
US$ 27.02
US$ 28.22
US$ 25.21
